SAM
CERE

Stansberry Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Stansberry Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-281,694
Closed -$11.5M – 131
2024
Q2 		$11.5M Buy
281,694
+91,906
+48% +$3.76M 1.51% 23
2024
Q1 		$8.02M Buy
+189,788
New +$8.02M 1.08% 34